Challenges to the development of new agents for molecularly defined patient subsets: lessons from BRCA1/2-associated breast cancer. [electronic resource]
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology Nov 2011
- 4224-6 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1527-7755
10.1200/JCO.2011.36.8134 doi
Breast Neoplasms--drug therapy Enzyme Inhibitors--therapeutic use Female Genes, BRCA1 Genes, BRCA2 Humans Mutation Poly(ADP-ribose) Polymerase Inhibitors Research Design